Results 11 to 20 of about 28,197 (214)

Molecular and computational approaches to understand resistance of New Delhi metallo β-lactamase variants (NDM-1, NDM-4, NDM-5, NDM-6, NDM-7)-producing strains against carbapenems

open access: yesJournal of Biomolecular Structure and Dynamics, 2018
The discovery of NDM-1 and its variants has caused the emergence of antibiotic resistance in the community and hospital setting, causing major concern for health care across the globe. New Delhi Metallo-β-lactamase is known to hydrolyse almost all β-lactam antibiotics.
Abid Ali   +4 more
openaire   +3 more sources

Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9 [PDF]

open access: yesFrontiers in Microbiology, 2023
Here, we characterized the first French NDM-9-producing Acinetobacter baumannii isolate. A. baumannii 13A297, which belonged to the STPas25 (international clone IC7), was highly resistant to β-lactams including cefiderocol (MIC >32 mg/L). Whole genome
Susie Gaillot   +16 more
doaj   +3 more sources

PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against Enterobacteriaceae producing NDM-1 [PDF]

open access: yesFrontiers in Microbiology, 2023
IntroductionWith the increasingly serious problem of bacterial drug resistance caused by NDM-1, it is an important strategy to find effective inhibitors to assist β-lactam antibiotic treatment against NDM-1 resistant bacteria.
Xiaohui Li   +11 more
doaj   +2 more sources

INFECTIONS CAUSED BY NDM- AND NDM+KPC-PRODUCING ENTEROBACTERALES: EPIDEMIOLOGICAL PROFILE IN A UNIVERSITY HOSPITAL

open access: yesThe Brazilian Journal of Infectious Diseases
Introduction/Objective: The production of New Delhi Metallo-β-lactamase (NDM) by Enterobacterales has a major impact on antimicrobial therapy, particularly in multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, significantly limiting ...
Rafael Amoroso Santos   +10 more
openaire   +2 more sources

Author Correction: A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation

open access: yesScientific Reports, 2021
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Sohaib Nizami   +9 more
doaj   +1 more source

The First Experience of Combined Use of Cefepime/Sulbactam and Aztreonam in ICU Patients with Nosocomial Infections Caused by Carbapenem-Resistant Gram-Negative Microorganisms Producing Class B and D Carbapenemases

open access: yesАнтибиотики и Химиотерапия, 2023
Background. The difficulties of antibacterial therapy of infections caused by carbapenemase-producing  gram-negative bacteria are associated with limited options for adequate therapy since, in addition to resistance to carbapenems and other beta-lactams ...
M. P. Suvorova   +7 more
doaj   +1 more source

Clinical and molecular characterization of NDM-9 and NDM-13 producing multidrug-resistant Escherichia coli strains in China

open access: yesBMC Microbiology
Objectives The continuous evolution of NDM variants, some of which exhibit enhanced hydrolytic activity, poses a serious public health threat and necessitates ongoing surveillance.
Jia Tao   +12 more
doaj   +4 more sources

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales

open access: yesRambam Maimonides Medical Journal, 2022
Objective Israeli hospitals were confronted with a major national outbreak of carbapenemase-producing Enterobacterales (CPE) starting in 2006, caused predominantly by monoclonal Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ...
Khetam Hussein   +7 more
doaj   +1 more source

egemenimre/ccsds-ndm: Minor fix for Combined NDM output to KVN

open access: yes, 2021
Added proper error message to Combined NDM output to ...
Egemen Imre, Tevfik Uyar, Agit
core   +1 more source

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance

open access: yesNature Communications, 2023
Approximately 10% of antimicrobials used by humans in low- and middle-income countries are estimated to be substandard or falsified. In addition to their negative impact on morbidity and mortality, they may also be important drivers of antimicrobial ...
Sean Cavany   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy